NUZZO, TOMMASO
 Distribuzione geografica
Continente #
EU - Europa 288
NA - Nord America 256
AS - Asia 48
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 594
Nazione #
US - Stati Uniti d'America 252
IE - Irlanda 149
IT - Italia 48
GB - Regno Unito 33
SG - Singapore 25
UA - Ucraina 17
CN - Cina 13
GR - Grecia 13
DE - Germania 8
FI - Finlandia 8
CA - Canada 4
FR - Francia 4
TR - Turchia 4
IN - India 3
PK - Pakistan 3
AT - Austria 2
NL - Olanda 2
SE - Svezia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
CZ - Repubblica Ceca 1
NZ - Nuova Zelanda 1
Totale 594
Città #
Dublin 144
Chandler 46
Jacksonville 36
Princeton 20
Roxbury 19
Caserta 14
Singapore 13
Cambridge 11
Medford 9
New York 6
Santa Maria Capua Vetere 6
Beijing 5
Salerno 5
Ann Arbor 4
Boardman 4
Naples 4
Norwalk 4
Andover 3
Delhi 3
Des Moines 3
Formia 3
Houston 3
San Mateo 3
Amsterdam 2
Auburn Hills 2
Bremen 2
Dearborn 2
Foggia 2
Islamabad 2
Lappeenranta 2
London 2
Lucca 2
Mountain View 2
Redmond 2
Toronto 2
Vienna 2
Wilmington 2
Woodbridge 2
Angri 1
Ashburn 1
Brdo 1
Brussels 1
Cava 1
Chengdu 1
Chicago 1
Elora 1
Fairfield 1
Fuzhou 1
Hanover 1
Hebei 1
Hefei 1
Helsinki 1
Indianapolis 1
Jinan 1
Marigliano 1
Montréal 1
Nanjing 1
Napoli 1
Nelson 1
Rawalpindi 1
Redwood City 1
Scafati 1
Scottsdale 1
Totale 423
Nome #
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 78
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity. 62
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons. 43
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain 34
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 33
Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients 33
Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease. 29
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients 29
D-aspartate oxidase gene duplication induces social recognition memory deficit in mice and intellectual disabilities in humans 27
Decreased free d -aspartate levels are linked to enhanced d -aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients 27
The Emerging Role of Altered D-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies 21
The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses 21
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 21
Dysfunctional d-aspartate metabolism in BTBR mouse model of idiopathic autism. 21
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients 20
Free D-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking D-aspartate oxidase activity 20
New evidence on the role of d‐aspartate metabolism in regulating brain and endocrine system physiology: From preclinical observations to clinical applications 18
Selective demethylation of two CpG sites causes postnatal activation of the Dao gene and consequent removal of d-serine within the mouse cerebellum 17
Prenatal and Early Postnatal Cerebral d-Aspartate Depletion Influences l-Amino Acid Pathways, Bioenergetic processes, and Developmental Brain Metabolism 16
Prenatal expression of D-aspartate oxidase causes early cerebral D-aspartate depletion and influences brain morphology and cognitive functions at adulthood. 15
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 15
RasGRP1 is a causal factor in the development of l-DOPA-induced dyskinesia in Parkinson's disease. 14
Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy 11
High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease 10
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy 5
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 4
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 2
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration 2
Totale 648
Categoria #
all - tutte 3.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 9 5 0 0 9 8 16 11 2 0 0 0
2020/202159 2 0 7 5 5 1 11 4 3 7 13 1
2021/2022111 3 0 0 0 33 0 3 4 2 14 11 41
2022/2023240 21 2 6 18 21 18 0 12 128 1 3 10
2023/2024122 6 2 4 6 38 9 24 2 2 0 6 23
Totale 648